227 related articles for article (PubMed ID: 29674751)
1. Characterization of the most frequent ATP7B mutation causing Wilson disease in hepatocytes from patient induced pluripotent stem cells.
Parisi S; Polishchuk EV; Allocca S; Ciano M; Musto A; Gallo M; Perone L; Ranucci G; Iorio R; Polishchuk RS; Bonatti S
Sci Rep; 2018 Apr; 8(1):6247. PubMed ID: 29674751
[TBL] [Abstract][Full Text] [Related]
2. Pluripotent stem cell-derived bile canaliculi-forming hepatocytes to study genetic liver diseases involving hepatocyte polarity.
Overeem AW; Klappe K; Parisi S; Klöters-Planchy P; Mataković L; du Teil Espina M; Drouin CA; Weiss KH; van IJzendoorn SCD
J Hepatol; 2019 Aug; 71(2):344-356. PubMed ID: 30965071
[TBL] [Abstract][Full Text] [Related]
3. An αB-Crystallin Peptide Rescues Compartmentalization and Trafficking Response to Cu Overload of ATP7B-H1069Q, the Most Frequent Cause of Wilson Disease in the Caucasian Population.
Allocca S; Ciano M; Ciardulli MC; D'Ambrosio C; Scaloni A; Sarnataro D; Caporaso MG; D'Agostino M; Bonatti S
Int J Mol Sci; 2018 Jun; 19(7):. PubMed ID: 29954118
[TBL] [Abstract][Full Text] [Related]
4. A systems biology approach reveals new endoplasmic reticulum-associated targets for the correction of the ATP7B mutant causing Wilson disease.
Concilli M; Iacobacci S; Chesi G; Carissimo A; Polishchuk R
Metallomics; 2016 Sep; 8(9):920-930. PubMed ID: 27714068
[TBL] [Abstract][Full Text] [Related]
5. A new Caenorhabditis elegans model to study copper toxicity in Wilson disease.
Catalano F; O'Brien TJ; Mekhova AA; Sepe LV; Elia M; De Cegli R; Gallotta I; Santonicola P; Zampi G; Ilyechova EY; Romanov AA; Samuseva PD; Salzano J; Petruzzelli R; Polishchuk EV; Indrieri A; Kim BE; Brown AEX; Puchkova LV; Di Schiavi E; Polishchuk RS
Traffic; 2024 Jan; 25(1):e12920. PubMed ID: 37886910
[TBL] [Abstract][Full Text] [Related]
6. Pharmacoproteomics pinpoints HSP70 interaction for correction of the most frequent Wilson disease-causing mutant of ATP7B.
Concilli M; Petruzzelli R; Parisi S; Catalano F; Sirci F; Napolitano F; Renda M; Galietta LJV; Di Bernardo D; Polishchuk RS
Proc Natl Acad Sci U S A; 2020 Dec; 117(51):32453-32463. PubMed ID: 33288711
[TBL] [Abstract][Full Text] [Related]
7. Identification of p38 MAPK and JNK as new targets for correction of Wilson disease-causing ATP7B mutants.
Chesi G; Hegde RN; Iacobacci S; Concilli M; Parashuraman S; Festa BP; Polishchuk EV; Di Tullio G; Carissimo A; Montefusco S; Canetti D; Monti M; Amoresano A; Pucci P; van de Sluis B; Lutsenko S; Luini A; Polishchuk RS
Hepatology; 2016 Jun; 63(6):1842-59. PubMed ID: 26660341
[TBL] [Abstract][Full Text] [Related]
8. Defective cellular localization of mutant ATP7B in Wilson's disease patients and hepatoma cell lines.
Huster D; Hoppert M; Lutsenko S; Zinke J; Lehmann C; Mössner J; Berr F; Caca K
Gastroenterology; 2003 Feb; 124(2):335-45. PubMed ID: 12557139
[TBL] [Abstract][Full Text] [Related]
9. Reduced expression of ATP7B affected by Wilson disease-causing mutations is rescued by pharmacological folding chaperones 4-phenylbutyrate and curcumin.
van den Berghe PV; Stapelbroek JM; Krieger E; de Bie P; van de Graaf SF; de Groot RE; van Beurden E; Spijker E; Houwen RH; Berger R; Klomp LW
Hepatology; 2009 Dec; 50(6):1783-95. PubMed ID: 19937698
[TBL] [Abstract][Full Text] [Related]
10. Functional analysis and drug response to zinc and D-penicillamine in stable ATP7B mutant hepatic cell lines.
Chandhok G; Horvath J; Aggarwal A; Bhatt M; Zibert A; Schmidt HH
World J Gastroenterol; 2016 Apr; 22(16):4109-19. PubMed ID: 27122662
[TBL] [Abstract][Full Text] [Related]
11. Generation of two induced pluripotent stem cell lines from a female adult homozygous for the Wilson disease associated ATP7B variant p.H1069Q (AKOSi008-A) and a healthy control (AKOSi009-A).
Petters J; Völkner C; Krohn S; Murua Escobar H; Bullerdiek J; Reuner U; Frech MJ; Hermann A; Lukas J
Stem Cell Res; 2020 Dec; 49():102079. PubMed ID: 33197697
[TBL] [Abstract][Full Text] [Related]
12. Copper-dependent trafficking of Wilson disease mutant ATP7B proteins.
Forbes JR; Cox DW
Hum Mol Genet; 2000 Aug; 9(13):1927-35. PubMed ID: 10942420
[TBL] [Abstract][Full Text] [Related]
13. Systemic deletion of Atp7b modifies the hepatocytes' response to copper overload in the mouse models of Wilson disease.
Muchenditsi A; Talbot CC; Gottlieb A; Yang H; Kang B; Boronina T; Cole R; Wang L; Dev S; Hamilton JP; Lutsenko S
Sci Rep; 2021 Mar; 11(1):5659. PubMed ID: 33707579
[TBL] [Abstract][Full Text] [Related]
14. p.H1069Q mutation in ATP7B and biochemical parameters of copper metabolism and clinical manifestation of Wilson's disease.
Gromadzka G; Schmidt HH; Genschel J; Bochow B; Rodo M; Tarnacka B; Litwin T; Chabik G; Członkowska A
Mov Disord; 2006 Feb; 21(2):245-8. PubMed ID: 16211609
[TBL] [Abstract][Full Text] [Related]
15. Characterization of mutation spectrum and identification of novel mutations in ATP7B gene from a cohort of Wilson disease patients: Functional and therapeutic implications.
Kumari N; Kumar A; Thapa BR; Modi M; Pal A; Prasad R
Hum Mutat; 2018 Dec; 39(12):1926-1941. PubMed ID: 30120852
[TBL] [Abstract][Full Text] [Related]
16. ATP7B gene therapy of autologous reprogrammed hepatocytes alleviates copper accumulation in a mouse model of Wilson's disease.
Cai H; Cheng X; Wang XP
Hepatology; 2022 Oct; 76(4):1046-1057. PubMed ID: 35340061
[TBL] [Abstract][Full Text] [Related]
17. Wilson disease protein ATP7B utilizes lysosomal exocytosis to maintain copper homeostasis.
Polishchuk EV; Concilli M; Iacobacci S; Chesi G; Pastore N; Piccolo P; Paladino S; Baldantoni D; van IJzendoorn SC; Chan J; Chang CJ; Amoresano A; Pane F; Pucci P; Tarallo A; Parenti G; Brunetti-Pierri N; Settembre C; Ballabio A; Polishchuk RS
Dev Cell; 2014 Jun; 29(6):686-700. PubMed ID: 24909901
[TBL] [Abstract][Full Text] [Related]
18. Activation of Autophagy, Observed in Liver Tissues From Patients With Wilson Disease and From ATP7B-Deficient Animals, Protects Hepatocytes From Copper-Induced Apoptosis.
Polishchuk EV; Merolla A; Lichtmannegger J; Romano A; Indrieri A; Ilyechova EY; Concilli M; De Cegli R; Crispino R; Mariniello M; Petruzzelli R; Ranucci G; Iorio R; Pietrocola F; Einer C; Borchard S; Zibert A; Schmidt HH; Di Schiavi E; Puchkova LV; Franco B; Kroemer G; Zischka H; Polishchuk RS
Gastroenterology; 2019 Mar; 156(4):1173-1189.e5. PubMed ID: 30452922
[TBL] [Abstract][Full Text] [Related]
19. ATP7B-Deficient Hepatocytes Reveal the Importance of Protein Misfolding Induced at Low Copper Concentration.
Charbonnier P; Chovelon B; Ravelet C; Ngo TD; Chevallet M; Deniaud A
Cells; 2022 Oct; 11(21):. PubMed ID: 36359796
[TBL] [Abstract][Full Text] [Related]
20. Generation of induced pluripotent stem cell lines AKOSi002-A and AKOSi003-A from symptomatic female adults with Wilson disease.
Petters J; Cimmaruta C; Iwanov K; Chang ML; Völkner C; Knuebel G; Murua Escobar H; Frech MJ; Hermann A; Rolfs A; Lukas J
Stem Cell Res; 2020 Mar; 43():101708. PubMed ID: 32028086
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
